couple of things...
1. i hate those reporting standards (much prefer Aussie)
2. Revenue down due to covid 36% - seems alot but no real surprise
3. Net loss after tax - good. due to significant reduction in operating costs (lines up with last weeks announcement)
4. couldnt work out why the drop in NTA:
had to go to the full report to find out:
5. they have 250m (rand) in cash
6. the DCF loan is at 570m (rand). Thats a key US stakeholder. Now compare to the Top 20 - lots of Chinese based owners.
US is financing a chinese owned company. There must be some serious helium for a geo-political ownership stoush to happen
7. No drilling update but these are points of interest:
Also i dont like mistakes in these reports. small as they may be it looks sloppy.
a) should this read 2020 (instead of 2019)???
- Forums
- ASX - By Stock
- RLT
- Ann: Appendix 4D
Ann: Appendix 4D, page-4
Featured News
Add RLT (ASX) to my watchlist
(20min delay)
|
|||||
Last
77.8¢ |
Change
-0.023(2.81%) |
Mkt cap ! $24.26M |
Open | High | Low | Value | Volume |
78.0¢ | 78.0¢ | 77.5¢ | $4.211K | 5.409K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1863 | 77.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
78.0¢ | 8993 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1863 | 0.775 |
1 | 2045 | 0.750 |
2 | 25050 | 0.745 |
1 | 50 | 0.740 |
1 | 50 | 0.735 |
Price($) | Vol. | No. |
---|---|---|
0.780 | 8993 | 4 |
0.785 | 50 | 1 |
0.790 | 50 | 1 |
0.810 | 45706 | 1 |
0.850 | 11662 | 1 |
Last trade - 12.57pm 13/11/2024 (20 minute delay) ? |
Featured News
RLT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online